Product Details for: Inmazeb

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
241.7MG, 241.7MG, 241.7MG/14.5ML (16.67MG, 16.67MG, 16.67MG/ML)
Single-Dose Vial
351(a)
Inmazeb
Rx
002
Injection
Intravenous
483.3MG, 483.3MG, 483.3MG/14.5ML (33.33MG, 33.33MG, 33.33MG/ML)
Single-Dose Vial
351(a)
Inmazeb
Rx
Proper Name
atoltivimab, maftivimab, and odesivimab-ebgn
BLA Number
761169
Applicant
Regeneron Pharmaceuticals, Inc.
Original Approval Date
October 14, 2020
Date of First Licensure
RETURN TO SEARCH RESULTS